Cancer Risks for PMS2-Associated Lynch Syndrome
- Author(s):
- Broeke, S.W. ten; Klift, H.M. van der; Tops, C.M.J.; Aretz, S.; Bernstein, I.; Buchanan, D.D.; Chapelle, A. de la; Capella, G.; Clendenning, M.; Engel, C.; Gallinger, S.; Gomez Garcia, E.; Figueiredo, J.C.; Haile, R.; Hampel, H.L.; Hopper, J.L.; Hoogerbrugge, N.; Doeberitz, M.V.; Marchand, L. le; Letteboer, T.G.W.; Jenkins, M.A.; Lindblom, A.; Lindor, N.M.; Mensenkamp, A.R.; Moller, P.; Newcomb, P.A.; Os, T.A.M. van; Pearlman, R.; Pineda, M.; Rahner, N.; Redeker, E.J.W.; Olderode-Berends, M.J.W.; Rosty, C.; Schackert, H.K.; Scott, R.; Senter, L.; Spruijt, L.; Steinke-Lange, V.; Suerink, M.; Thibodeau, S.; Vos, Y.J.; Wagner, A.; Winship, I.; Hes, F.J. (0000-0002-3025-0882); Vasen, H.F.A.; Wijnen, J.T.; Nielsen, M.; Win, A.K.
- Published
- 2018
- Publication type
- Article / Letter to editor
- Date issued
- 2018-10-10
- Language
- English
- Is part of
- Journal of Clinical Oncology (2018), Vol. 36, no. 29, p. 2961-+
- hdl
- 1887/77617
- doi
- 10.1200/JCO.2018.78.4777
